Existing investor Camber Creek returned for a round that increased the total raised by the property appraisal software provider to $19m.
Month: January 2019
Horizn Studios carries away series B funding
Vorwerk Ventures returned to reinvest in the smart luggage developer as part of an $11.4m round that also featured Project A and Milano Investment Partners.
Alector selects Nasdaq for $150m IPO
MRL Ventures, GV, AbbVie Ventures, Lilly Asia Ventures and Amgen Ventures are all in line to exit the immuno-neurology drug developer.
Quovo plugs into Plaid in $200m acquisition
Salesforce and Power Financial are set to exit Quovo, a fintech developer that had secured $20m in capital, in a purchase by Plaid for up to $200m.
CloudEndure undergoes $200m acquisition by Amazon
Amazon has purchased CloudEndure, a data recovery technology producer that had raised more than $18m from investors including Infosys, Dell EMC and Mitsui, for $200m.
Providence Ventures produces $150m second fund
The Providence St Joseph Health-managed corporate venturing unit has doubled its capital reserves to $300m by launching a second fund.
Frequency tunes into $42m
Proceeds from the Alexandria Real Estate Equities-backed series B round will advance the company’s development of progenitor cell-related medicines for hearing loss.
Celgene injects $30m into NantCell
NantCell received the funding at a $4bn valuation, giving existing investor Celgene a 2.8% stake in the cancer immunotherapy developer.
Pear prevails in $64m series C
Novartis returned to reinvest in digital medicine developer Pear Therapeutics as part of a Temasek-led round that took its overall funding to more than $134m.
Haoqipei hops to $60m series C
Access Industries and SIG participated in a series C round that came three months after the auto parts marketplace raised $20m in series B funding.
Super League seeks $25m in IPO
Cali Group owns a 17.6% in the online gaming platform and eSports tournament operator, whose other investors include Viacom, Axiomatic, DMG and Cinemark.
WeRide drives away with series A extension
SenseTime has helped the autonomous driving software developer expand a series A round already featuring Alliance Ventures and Johnson Electric.
Exscientia sends for $26m
Celgene and Evotec both invested in Exscientia, as the automated drug discovery services provider added Roche to its roster of development partners.
Mitsui Fudosan pinpoints GeoSpock for more funding
Big data technology developer GeoSpock more than doubled its overall funding to $24.5m in a $12.8m round co-led by Mitsui Fudosan.